The Summit for High-Potency Drug Development
MaxPotent Pharma Summit is an invite-only international platform for the people who design, run, regulate and supply HPAPI manufacturing.
The 3rd Annual MaxPotent Pharma Summit is the international meeting point for Highly Potent Active Pharmaceutical Ingredients, bringing senior executives, regulatory authorities, technology providers and pharmaceutical innovators into one room.
Ten agenda themes, 22 sessions and 60+ companies represented to date. Two intensive days on EU and global regulatory frameworks, containment and isolation technology, automation and process engineering, occupational health and safety, scale-up, and supply chain resilience.
150+ senior professionals and 20+ industry experts, in Rome, on 21–22 April 2027. A focused, high-density summit built to deliver real commercial and industry value, with particular emphasis on CDMO and CMO partnership models and sustainability in high-potency operations.
At a glance
3rd Annual, Rome
21–22 April 2027
Rome, Italy
2-day in-person conference
150+ senior professionals
20+ industry experts
HPAPI manufacturing & containment
Convolign Business Consulting
What Makes Our Programme Unique
Our team of producers and analysts invests over a year of preparation to study market dynamics, regulatory changes, and upcoming innovations. This invite-only summit is designed exclusively for HPAPI professionals who want to stay ahead of industry trends and strengthen their expertise. It is the essential platform for knowledge exchange, career advancement, and shaping the future of high-potency drug development.
Expert Presentations
Gain access to keynote sessions that deliver deep market insights, scientific expertise, and strategic guidance in HPAPI manufacturing and handling, offering a global perspective that empowers professionals to make informed, forward-looking decisions.
Dynamic Panel Discussions
Join interactive panels where experts dissect emerging challenges, debate solutions, and exchange forward-thinking strategies. These sessions encourage knowledge-sharing and provide a forum to shape best practices in the industry.
Facilitated Networking
Engage with senior peers, industry leaders, and innovators in structured networking sessions that enable meaningful dialogue, collaborative opportunities, and partnerships that last well beyond the conference.
Collaborative Environment
Be part of an environment built on collaboration and innovation, where ideas flow freely, challenges are addressed collectively, and actionable solutions are developed to advance HPAPI practices across the sector.
Who Should Attend
Seniority
From Pharmaceutical, Biopharmaceutical, and Contract Manufacturing organisations
Key departments
The Themes We Return to Every Year
Regulatory Compliance
Updates and insights into navigating HPAPI-specific regulations and global standards.
Containment Technologies
Latest innovations to ensure safe handling of high-potency compounds.
Process Optimisation
Best practices for efficient, scalable and risk-controlled manufacturing.
Risk Mitigation & Safety
Strategies for minimising exposure, ensuring worker safety and maintaining environmental compliance.
Networking & Collaboration
Opportunities to build partnerships and foster knowledge exchange among pharma innovators, CMOs/CDMOs and regulatory experts.
Market Insights
Understanding trends in HPAPI demand, technology adoption and growth projections.
Thought Leadership
Keynote sessions and panel discussions featuring industry leaders and subject-matter experts.
CDMO Insights
Strategies for CMOs/CDMOs to enhance operational efficiency, expand service offerings and collaborate with pharma innovators.
The MaxPotent Story So Far
From a gap in the European conference calendar to a three-edition series.
Identifying the gap
Convolign Business Consulting identified a critical gap in the European conference landscape: no event was dedicated exclusively to the full HPAPI value chain. Speaker recruitment and programme development began, with strong early interest from the European biopharma community.
Inaugural edition, Milan 2025
The 1st Annual MaxPotent Pharma Summit took place at Duo Milan Porta Nuova on 25–26 September 2025, establishing the themes the series returns to every year: regulatory compliance, containment technology, process optimisation, risk mitigation and occupational safety.
2nd Annual edition, Milan 2026
The summit returned to Milan on 6–7 May 2026 at the Ramada Plaza by Wyndham with an expanded programme: 20+ speakers, 22 sessions across two days, and 60+ companies represented.
3rd Annual edition, Rome 2027
The third edition moves to Rome on 21–22 April 2027, with four themed sessions, two keynotes and two industry panels spanning manufacturing, CDMO partnership, facility design and sustainability.
The People Behind MaxPotent
The summit is organised and delivered by the team at Convolign Business Consulting, a specialist life sciences consultancy focused on conference production, market intelligence and strategic advisory services.
Madhumati Patil
Oversees programme planning, speaker management and event execution, and is the first point of contact for speaking, panel and moderator enquiries.
madhumati@convolign.com +91 98608 51975
Akshita Lohia
Leads sponsorship and exhibition partnerships for the MaxPotent Pharma Summit, and is the first point of contact for packages, exhibition space and branding.
akshita@convolign.com +1-617-213-1431
Anupama
Looks after delegate registration, group bookings and on-site attendance, and answers questions about passes, invoicing and accommodation.
anupama@convolign.com +1-617-213-1431Who Runs the Summit
Conceptualised by Convolign Business Consulting
The MaxPotent Pharma Summit is produced by Convolign Business Consulting. Our producers and analysts spend more than a year researching each edition, tracking market dynamics, regulatory change and emerging technology, so the programme reflects what the industry actually needs to discuss.